Evidence map›Paper›PMID 33780518›Full record

ArticlePLoS pathogens2021

Determining Aspergillus fumigatus transcription factor expression and function during invasion of the mammalian lung.

Hong Liu, Wenjie Xu, Vincent M Bruno, Quynh T Phan, Norma V Solis, Carol A Woolford, Rachel L Ehrlich, Amol C Shetty, Carrie McCraken, Jianfeng Lin and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Non-viableMicrobiology spectrum · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Pathogenesis and Triazole Resistance inInfection and drug resistance · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Recent developments inMicrobiology and molecular biology reviews : MMBR · 2025
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Hong LiuDivision of Infectious Diseases, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, United States of America.
Wenjie XuDepartment of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA, United States of America.ORCID 0000-0001-6978-9087
Vincent M BrunoDepartment of Microbiology and Immunology, University of Maryland, Baltimore, MD, United States of America.
Quynh T PhanDivision of Infectious Diseases, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, United States of America.
Norma V SolisDivision of Infectious Diseases, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, United States of America.
Carol A WoolfordDepartment of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA, United States of America.ORCID 0000-0001-6261-3468
Rachel L EhrlichDepartment of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA, United States of America.
Amol C ShettyInstitute for Genome Sciences, University of Maryland, Baltimore, MD, United States of America.ORCID 0000-0001-8790-7649
Carrie McCrakenInstitute for Genome Sciences, University of Maryland, Baltimore, MD, United States of America.ORCID 0000-0002-8038-9727
Jianfeng LinDivision of Infectious Diseases, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, United States of America.ORCID 0000-0002-5202-6304
Michael J BromleyManchester Fungal Infection Group, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Core Technology Facility, and Lydia Becker Institute of Immunology and Inflammation, Biology, Medicine and Health. The University of Manchester, Manchester Academic Health Science Centre, MA, United Kingdom.ORCID 0000-0002-7611-0201
Aaron P MitchellDepartment of Biological Sciences, Carnegie Mellon University, Pittsburgh, PA, United States of America.ORCID 0000-0002-0868-4000
Scott G FillerDivision of Infectious Diseases, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA, United States of America.ORCID 0000-0001-7278-3700
UCLA Medical Center · USCarnegie Mellon University · USUniversity of Maryland, Baltimore · USManchester Academic Health Science Centre · GBUniversity of California, Los Angeles · USUniversity of Georgia · US

Funding

Technology CoreU19AI110820 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI CARNEIRO DA SILVA, JOANA · 2014 to 2023
$36.5M
Candida albicans Epithelial Cell Interactions and Oropharyngeal DiseaseR01DE017088 · NIDCR · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI FILLER, SCOTT G · 2005 to 2014
$3.4M
C. albicans invasion and proliferation during oral infectionR01DE026600 · NIDCR · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI FILLER, SCOTT G, MITCHELL, AARON P · 2017 to 2021
$3.0M
Endothelial invasion by yeast-phase CandidaR01AI124566 · NIAID · LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER · PI FILLER, SCOTT G, MITCHELL, AARON P · 2016 to 2020
$2.7M
Therapeutic targeting of growth factor receptors to treat MucormycosisR01AI141360 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI BRUNO, VINCENT MICHAEL · 2019 to 2023
$2.5M
NIAID NIH HHS R01 AI124566NIAID NIH HHS R01 AI141360NIAID NIH HHS U19 AI110820NIDCR NIH HHS R01 DE017088NIDCR NIH HHS R01 DE026600Wellcome TrustWellcome Trust 208396/Z/17/Z
6 · The paper itself

Abstract

To gain a better understanding of the transcriptional response of Aspergillus fumigatus during invasive pulmonary infection, we used a NanoString nCounter to assess the transcript levels of 467 A. fumigatus genes during growth in the lungs of immunosuppressed mice. These genes included ones known to respond to diverse environmental conditions and those encoding most transcription factors in the A. fumigatus genome. We found that invasive growth in vivo induces a unique transcriptional profile as the organism responds to nutrient limitation and attack by host phagocytes. This in vivo transcriptional response is largely mimicked by in vitro growth in Aspergillus minimal medium that is deficient in nitrogen, iron, and/or zinc. From the transcriptional profiling data, we selected 9 transcription factor genes that were either highly expressed or strongly up-regulated during in vivo growth. Deletion mutants were constructed for each of these genes and assessed for virulence in mice. Two transcription factor genes were found to be required for maximal virulence. One was rlmA, which is required for the organism to achieve maximal fungal burden in the lung. The other was sltA, which regulates of the expression of multiple secondary metabolite gene clusters and mycotoxin genes independently of laeA. Using deletion and overexpression mutants, we determined that the attenuated virulence of the ΔsltA mutant is due in part to decreased expression aspf1, which specifies a ribotoxin, but is not mediated by reduced expression of the fumigaclavine gene cluster or the fumagillin-pseruotin supercluster. Thus, in vivo transcriptional profiling focused on transcription factors genes provides a facile approach to identifying novel virulence regulators.

Indexed as

AnimalsAspergillosisAspergillus fumigatusFungal ProteinsGene Expression ProfilingGene Expression Regulation, FungalIronLungMiceTranscription FactorsVirulenceFungal ProteinsIronTranscription Factors

Identifiers

PMID33780518
PMCPMC8031882
OpenAlexW3147705625

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.